IVD Firms Report Strong Growth Because of COVID-19 Testing -

TO NO ONE’S SURPRISE, THOSE IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS that produce molecular tests, instruments, and automation used for COVID-19 testing reported strong growth in revenue and profits during 2020. In recent weeks, these companies issued their earnings reports for the fourth quarter 2020 and full year 2020. As expected, most companies announced substantial increases …

IVD Firms Report Strong Growth Because of COVID-19 Testing Read More »

To access this post, you must purchase The Dark Report.

IVD Firms Report Strong Growth Because of COVID-19 Testing

For most of the world’s in vitro diagnostics (IVD) companies, 2020 shaped up to be a stellar year

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month